{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,18]],"date-time":"2026-11-18T14:21:06Z","timestamp":1795011666123,"version":"4.9.1"},"reference-count":12,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"6","funder":[{"name":"Institut National du Cancer"},{"name":"Banque des Territoires"}],"content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2026,11]]},"abstract":"<jats:sec>\n                    <jats:title\/>\n                    <jats:p>Cancer survivors face an increased risk of second primaries, but adherence to cancer screening and prevention recommendations remains limited. Post-treatment follow-up visits represent teachable moments for health promotion, including prevention of second primary cancers. We assessed practices and perceptions of second cancer screening and prevention among French hospital-based oncology health care professionals. An anonymous online survey using Likert scale was conducted. Clustering identified three prevention activity profiles (low, intermediate, high), and multinomial logistic regression explored associated factors. The median declared promotion activity of the 415 respondents was 8 for mammographic screening ([interquartile range: 5\u201310), 7 (2\u20139) for cervical cancer screening, 5 (1\u20137) for colorectal screening, 9 (7\u201310) for smoking cessation, and 7 (5\u20139) for alcohol control. Seventy-five percent of respondents addressed obesity management if indicated. Perceived importance and feasibility of secondary prevention activities were high [9 (7\u201310) and 8 (6\u201310)]. A high prevention activity profile was associated with greater perceived importance of secondary prevention [odds ratio (OR) per one-point Likert-scale increase = 1.1, 95% confidence interval (CI): 1.04\u20131.2] and its feasibility (OR\u2005=\u20051.1, 95% CI: 1.06\u20131.14); and managing head and neck cancer patients (OR\u2005=\u20057.64, 95% CI 1.55\u201337.8). Lung and sarcoma specialists were less likely to be in the high prevention activity group. Hospital-based oncology health care professionals are aware of and engaged in second primary cancer prevention, though activity levels vary. Its generalization, organization, and development could improve cancer survivors\u2019 adherence to cancer prevention recommendations, and improve health impacts.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1097\/cej.0000000000001011","type":"journal-article","created":{"date-parts":[[2026,2,16]],"date-time":"2026-02-16T20:00:09Z","timestamp":1771272009000},"page":"584-588","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":1,"title":["Screening and prevention of second primary cancers by hospital-based oncology professionals"],"prefix":"10.1097","volume":"35","author":[{"given":"Tarek","family":"Ben Ahmed","sequence":"first","affiliation":[{"name":"Department of Cancer Medicine, Interception Programme, Gustave Roussy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pamela","family":"Abdayem","sequence":"additional","affiliation":[{"name":"Department of Cancer Medicine, Interception Programme, Gustave Roussy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elo\u00efse","family":"Dubois-Delaloge","sequence":"additional","affiliation":[{"name":"Data Science team, Inserm U981, Gustave Roussy, Universit\u00e9 Paris Saclay, Villejuif"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Claudia","family":"Lefeuvre-Plesse","sequence":"additional","affiliation":[{"name":"Department of Prevention, Centre Eug\u00e8ne Marquis, Rennes"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Olivier","family":"Caron","sequence":"additional","affiliation":[{"name":"Department of Cancer Medicine, Interception Programme, Gustave Roussy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thomas","family":"Pudlarz","sequence":"additional","affiliation":[{"name":"Department of Cancer Medicine, Interception Programme, Gustave Roussy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sandrine","family":"Boucher","sequence":"additional","affiliation":[{"name":"Unicancer, Paris"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Beatrice","family":"Fervers","sequence":"additional","affiliation":[{"name":"Department Prevention Cancer Environment and CANCEPT network, Centre Leon Berard, Lyon, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lucie","family":"Veron","sequence":"additional","affiliation":[{"name":"Department of Cancer Medicine, Interception Programme, Gustave Roussy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Suzette","family":"Delaloge","sequence":"additional","affiliation":[{"name":"Department of Cancer Medicine, Interception Programme, Gustave Roussy"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","published-online":{"date-parts":[[2026,2,17]]},"reference":[{"key":"R1-20261118","doi-asserted-by":"crossref","first-page":"100903","DOI":"10.1016\/j.lanepe.2024.100903","article-title":"Risks of second primary cancers among 584,965 female and male breast cancer survivors in England: a 25-year retrospective cohort study.","volume":"40","author":"Allen","year":"2024","journal-title":"Lancet Reg Health Eur"},{"key":"R2-20261118","first-page":"229","article-title":"Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries.","volume":"74","author":"Bray","year":"2024","journal-title":"CA Cancer J Clin"},{"key":"R3-20261118","doi-asserted-by":"crossref","first-page":"1147","DOI":"10.1016\/S1470-2045(23)00403-5","article-title":"Cancer germline predisposing variants and late mortality from subsequent malignant neoplasms among long-term childhood cancer survivors: a report from the St Jude Lifetime Cohort and the Childhood Cancer Survivor Study.","volume":"24","author":"Chen","year":"2023","journal-title":"Lancet Oncol"},{"key":"R4-20261118","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1001\/jamaoncol.2024.5381","article-title":"Estimation of cancer deaths averted from prevention, screening, and treatment efforts, 1975-2020.","volume":"11","author":"Goddard","year":"2024","journal-title":"JAMA Oncol"},{"key":"R5-20261118","doi-asserted-by":"crossref","first-page":"1793","DOI":"10.1007\/s10147-021-01963-3","article-title":"Second primary cancers: a retrospective analysis of real world data using the enhanced medical research engine ConSoRe in a French comprehensive cancer center.","volume":"26","author":"Heudel","year":"2021","journal-title":"Int J Clin Oncol"},{"key":"R6-20261118","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1186\/1471-2407-14-94","article-title":"The effect of patient characteristics on second primary cancer risk in France.","volume":"14","author":"J\u00e9gu","year":"2014","journal-title":"BMC Cancer"},{"key":"R7-20261118","doi-asserted-by":"crossref","first-page":"e083975","DOI":"10.1136\/bmj-2024-083975","article-title":"Second cancers in 475 000 women with early invasive breast cancer diagnosed in England during 1993-2016: population based observational cohort study.","volume":"390","author":"McGale","year":"2025","journal-title":"BMJ"},{"key":"R8-20261118","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1053\/j.seminoncol.2024.10.005","article-title":"Screening adherence for second primary malignancies in breast cancer survivors: behaviors, facilitators, and barriers to enhance quality care.","volume":"51","author":"Mesa-Chavez","year":"2024","journal-title":"Semin Oncol"},{"key":"R9-20261118","doi-asserted-by":"crossref","first-page":"2499","DOI":"10.1056\/NEJMoa1505949","article-title":"Second cancer risk up to 40 years after treatment for hodgkin\u2019s lymphoma.","volume":"373","author":"Schaapveld","year":"2015","journal-title":"N Engl J Med"},{"key":"R10-20261118","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1016\/j.annonc.2022.10.004","article-title":"Risk reduction and screening of cancer in hereditary breast-ovarian cancer syndromes: ESMO Clinical Practice Guideline.","volume":"34","author":"Sessa","year":"2023","journal-title":"Ann Oncol"},{"key":"R11-20261118","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1038\/nrclinonc.2013.41","article-title":"Aetiology, genetics and prevention of secondary neoplasms in adult cancer survivors.","volume":"10","author":"Travis","year":"2013","journal-title":"Nat Rev Clin Oncol"},{"key":"R12-20261118","doi-asserted-by":"crossref","first-page":"1119","DOI":"10.1016\/j.annonc.2022.07.1941","article-title":"ESMO Expert Consensus Statements on Cancer Survivorship: promoting high-quality survivorship care and research in Europe.","volume":"33","author":"Vaz-Luis","year":"2022","journal-title":"Ann Oncol"}],"container-title":["European Journal of Cancer Prevention"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/10.1097\/CEJ.0000000000001011","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,11,18]],"date-time":"2026-11-18T14:00:46Z","timestamp":1795010446000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/10.1097\/CEJ.0000000000001011"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,2,17]]},"references-count":12,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2026]]}},"URL":"https:\/\/doi.org\/10.1097\/cej.0000000000001011","relation":{},"ISSN":["0959-8278","1473-5709"],"issn-type":[{"value":"0959-8278","type":"print"},{"value":"1473-5709","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,2,17]]}}}